Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Dynamin 2 ELISA Kit (AC3223)
Cat.#: ASET-1812
Specifications
Description Human Dynamin 2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Dynamin 2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.33 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2069 Mouse Neurotensin ELISA Kit (AC3480) Quantitative inquiry ASET-2170 Rat Dopamine Receptor D1 ELISA Kit (AC3581) Quantitative inquiry ASET-1394 Mouse Semaphorin 7a ELISA Kit (AC2805) Quantitative inquiry ASET-1109 Human SNPH ELISA Kit (AC2520) Quantitative inquiry ASET-1957 Mouse Nmur1 ELISA Kit (AC3368) Quantitative inquiry ASET-2521 Human RKIP ELISA Kit (AC3932) Quantitative inquiry ASET-1053 Human Pea3 ELISA Kit (AC2464) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-2449 Human TPH2 ELISA Kit (AC3860) Quantitative inquiry ASET-2363 Human GFAP ELISA Kit (AC3774) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket